33
THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

Embed Size (px)

Citation preview

Page 1: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST

USING PERFORMANCE TARGETS

Raghu Loganathan, MD, FCCP

Director, Medical ICU & Stroke Center

March 2010

Page 2: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Disclosures

• Nothing extraordinary in the case reports

• Use 2 case studies to describe successful implementation of a new protocol

Page 3: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Cardiac Arrest Epidemiology

Out of Hospital cardiac arrests

• 64% of all arrests• 2 to 9% survive to discharge• 1/ 3rd of survivors have

irreversible cognitive dysfunction

In-hospital cardiac arrests

• 36 % of all arrests• 18% survive to

discharge

ILCOR 2008 Circulation 2008; 118:2452-83

Page 4: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

MILD THERAPUETIC HYPOTHERMIA CLINCIAL STUDIES

• RCT’s– Bernard S et al – NEJM 2002; 346(8)– Holtzer M et al – NEJM 2002; 346 (8)– Idrissi et al – NEJM 2001

• Other Designs– Benson D et al – Anaes Analg 1959; vol 38– Bernard S et al – Ann Emerg Med 1997; 33(2)– Bernard S et al – Resuscitation 2003; 56(1)

• Meta-analysis– Holtzer M et al – Crit Care Med 2005; 33(2)

Page 5: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Summary of Landmark Trials

HACA (European)

Bernard (Australian)

Initial rhythm VF or VT VF

Pre ED Cooling No Yes

Target Temp 32 to 33 C 33 C

Hypothermia patients 136 43

Standard Rx Patients 137 34

Hypothermia duration 24 hours 12 hours

Morbidity Reduction ARR 16%, NNT 6 ARR 16%, NNT 4

Mortality Reduction ARR 14%, NNT 6 ARR 17%, NNT 6

Adverse events (sepsis, arrhythmias & Bleeding)

NS NS

HACA study group, NEJM, 2002 & Bernard SA, NEJM 2002

Page 6: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

MILD THERAPEUTIC HYPOTHERMIAFDNY initiative

• Less than 15% hospitals are currently using hypothermia in US

• Designated hypothermia centers– Cardiac arrests triaged by EMS

• Model based on STEMI/ PCI centers & Stroke Centers

Page 7: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Case Study -1

• 69 year old male progressively dyspenic for 5 days• EMS found him cyanotic• Initial PEA, followed by asystole and V fib• Intubated on the field • Downtime 26 minutes

PMH: HTN, COPD, CAD, Morbid Obesity

• Arrived in ED comatose, GCS 3T

• PAP 54 on ventilator

Page 8: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Case Study -1

• Cold saline: 4.5 liters started within 5 minutes

• Surface cooling in 25 minutes

• Central line placed 30 minutes

• Initial Lactate was 9.3, ScVo2 65%

• Baseline Temp was 37.2

• Target temp reached in 3.4 hours– Double vests used in series

Page 9: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Case Study -1

• EKG: no STEMI

• Mild elevation of troponins

• ECHO showed depressed EF (30%) with wall motion abnormalities

• CXR showed lower lobe infiltrates

Page 10: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Case Study -1

• Posturing with de-cerebrating signs noted at 5 hours

• TH continued with sedation and paralytics for shivering

• Re-warming after 24 hours• EEG showed diffuse slowing, no seizures• No clinical response when sedation was stopped• Day 3; spontaneous eye opening and followed

some commands• Day 6 Able to follow more commands

Page 11: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Case Study -1

• Day 9: Unable to extubate transferred to vent floor

• Day 17 Trach done

• Day 23 weaned off Trach

• Day 25 discharged to SNF

• March 25th: Trach de-cannulated, ambulating and functioning at baseline

Page 12: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Case Study : 2

• 72 year old male well known to Lincoln BIBEMS• ESRD, Known asthma, Known CAD • EMS called for respiratory distress, “noted to

hypotensive and dyspneic and went into cardiac arrest”

• “Wide QRS on 3 lead” placed on NRB• Subsequently “patient agonal, PEA on monitor, 3

blocks from hospital, CPR started immediately”

• ED arrival 10 minutes later: CPR continued• Intubated in ED, various rhythms, 2 doses of

epinephrine and atropine given

Page 13: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Case Study : 2• Post intubation, noted to be “de-cerebrating” by ED

attending

• ROSC at 25 minutes: BP 143/ 76, RR 20 at set rate and Pulse 67

• MICU called for therapeutic hypothermia– Unresponsive to deep stimuli, comatose

• Hypothermia initiated 40 mins after ROSC• Myoclonic jerks observed day 1• 36 hours into protocol: patient opens eyes

and following simple commands

Page 14: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Who to Cool?Inclusion Criteria

• Post-cardiac arrest: defined as absence of pulses requiring chest compressions, regardless of location or presenting rhythm

• Any Initial rhythm (VF/VT, asystole or PEA)

• ROSC within 30 minutes to a SBP > 90 mmHg (with or without vasoactive meds)

• Patient is comatose (unable to follow commands/ GCS < 6) upon arrival to the hospital in the absence of sedation

• Time at start of cooling is within 4 hours after ROSC

Page 15: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Who to Cool?Exclusion Criteria

• Another reason to be comatose

• Purposeful response to verbal commands or noxious stimuli after ROSC and prior to initiation of hypothermia

• Absent brainstem function not explained by treatment with sedatives, paralytics or anti-cholinergic agents

• A known terminal illness preceding arrest

• ? Pregnancy ( Case report showing benefit)

Page 16: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Who to Cool?Exclusion Criteria

• Pre-existing DNR and / or DNI code status and patient not intubated as part of resuscitation efforts

• Multi-organ system failure, refractory shock requiring high doses of vasopressors (MAP<60 on 2 or more vasopressor agents), severe persistent hypoxia, acidosis or co-morbidities with minimal chance of meaningful survival independent of neurological status

• Uncontrolled bleeding to coagulopathy

• Recurrent VF or refractory VT in spite of appropriate therapy should generate consideration of emergent referral for cardiac catheterization          

Page 17: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RLAa

Aa

Typical Cooling and Rewarming Protocol

Page 18: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

How to Cool?ICU Notification

• Once eligibility for induced hypothermia is determined, call MICU/ Stroke attending ASAP

• Obtain 2 large bore IV lines

• Obtain baseline temperature

• Infusion of approximately 2 to 3 liters (for 70 kg individual) of normal saline refrigerated at 4-5 °C

– Can safely and reliably lower core body temperature by 3-4 °C when infused over 50 minutes.

Page 19: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

COOLING PROTOCOL• Obtain laboratory tests ASAP:

– Beta HCG on all women of childbearing age– Arterial blood gas– CBC/ platelets / PT / PTT/INR, Fibrinogen– Electrolyte “panel 7”, plus iCa / Mg / Phos , Cl-, Glucose– Amylase, Lipase, LFTs, , Lactate, CPK-MB, CK, Troponin– Blood Cultures, Urine Cultures, Urinalysis

• Toxicology screen if appropriate

• 12 lead EKG, Chest X-ray

• Placement of urinary catheter with temperature sensor

• Insertion of Central Line Catheter (subclavian or IJ)

Page 20: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

HYPOTHERMIA BUNDLE

TIME ZERO RETURN OF SPONTANEUOUS CIRCULATION (ROSC)

10 MINUTES COMPLETE SCREENING & NOTIFY ICU ATTENDING

15 MINUTES • “HYPOTHERMIA LABS” TO BE SENT OUT• START COLD SALINE

30 MINUTES PLACE CENTRAL LINE IN SUBCLAVIAN

PLACE TEMP SENSING FOLEY

45 MINUTES START SURFACE COOLING

4 HOURS ACHIEVE TARGET TEMP OF 32 C

Page 21: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

GAYMAR III Not selling this product

Page 22: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

14 PATIENTS COOLED

58 cardiac arrest patients to ED

22 patients in ED with ROSC

12 INPATIENTS COOLED

18 INPATIENTS screened

January 2009 to February 2010

Page 23: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Clinical Characteristics• 26 patients cooled

• Rhythm:– Vtach/ Vfib = 3 patients– Asystole/ PEA = 18– Mixed (VF with asystole/ PEA) = 5 patients

• Average APACHE II = 26 (predicted death rate of 64%)

• 22/ 26 had 100% compliance with hypothermia bundle

• Average ICU days on vent 7.03 days

Page 24: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

OUTCOMES• 26 patients cooled• 11/ 26 (42.3%) survived to hospital discharge • 10/ 26 (38.4%) had “good outcomes”

CPS category

Description Number

1 Conscious and alert with normal function or only slight disability

8

2 Conscious and alert with moderate disability 2

3 Conscious with severe disability 1

4 Comatose or persistent vegetative state 0

5 Brain dead or death from other causes 15

Page 25: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

OUTCOMES BY RHYTHM

Rhythm Cooled Survived

VF/ V-tach 3 1 (33.3%)

Asystole / PEA 18 8 (44.4%)

Mixed (VF/ V-tach and asytole / PEA)

5 2 (40%)

Page 26: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Summary of Studies Neurologic 50% vs 14%

Survival

50% vs 23%

Neurologic23% vs 7%

Survival54% vs 33%

Neurologic49% vs 26%

Survival48% vs 32%

Neurologic55% vs 39%

Survival59% vs 45%

Page 27: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Does Rhythm Matter?

• Data from RCTs”– Suggest VF and VT

• Combination of rhythms during a cardiac arrest event

• Underlying mechanisms of brain injury are same

• Multiple observational trials on asystolic rhythm have shown benefit

Who to Cool ?

Page 28: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Who to cool? Do Circumstances of Arrest Adequately Predict Outcome?

Practice Parameters: Prediction of outcome in comatose survivors after cardiopulmonary resuscitation, NEUROLOGY 2006;67:203–210

Page 29: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Complications

HACA study group, NEJM, 2002

Page 30: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

SUMMARY

• Screening of patients:– Judgement improves with time– Rhythm alone should not exclude patients

• Most have combined rhythms• Information on initial rhythm not always available

• Use of bundles helps with rapid implementation and achieving target temp– Performance targets helps

Page 31: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

FUTURE DIRECTIONS

• Phase 2 FDNY hypothermia– Cool Enroute to hospital

• MCA ischemic Infarcts

• Traumatic brain injury

• SAH patients with increased ICP

• Hepatic encephalopathy

Page 32: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

Old CPR

Page 33: THERAPEUTIC HYPOTHERMIA FOR CARDIAC ARREST USING PERFORMANCE TARGETS Raghu Loganathan, MD, FCCP Director, Medical ICU & Stroke Center March 2010

RL

HYPOTHERMIA